找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Diagnoses Without Names; Challenges for Medic Michael D. Lockshin,Mary K. Crow,Medha Barbhaiya Book 2022 Springer Nature Switzerland AG 202

[復(fù)制鏈接]
查看: 40054|回復(fù): 57
樓主
發(fā)表于 2025-3-21 17:26:38 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Diagnoses Without Names
副標(biāo)題Challenges for Medic
編輯Michael D. Lockshin,Mary K. Crow,Medha Barbhaiya
視頻videohttp://file.papertrans.cn/271/270542/270542.mp4
概述Examines the circumstances in which diagnosis names are unassignable.Explores how different stakeholders used diagnosis names for different purposes.Advocates for including diagnostic uncertainty in p
圖書封面Titlebook: Diagnoses Without Names; Challenges for Medic Michael D. Lockshin,Mary K. Crow,Medha Barbhaiya Book 2022 Springer Nature Switzerland AG 202
描述Doctors, patients, investigators, administrators, and policymakers who assign diagnoses assume three elements: the name describes an entity with conceptual or evidentiary boundaries, the person setting the name has a high degree of certainty, and the name has a consensus definition. This book challenges this practice and offers an alternative to assigning diagnoses: quantitating diagnostic uncertainty in personal and public medical plans..This book offers the stakeholders‘ views participating in a workshop, sponsored by the Barbara Volcker Center/Hospital for Special Surgery, taking place in April 2020, about uncertain diagnoses. Chapters examine the circumstances in which diagnosis names are "unassignable", either because patients do not fit within diagnostic "boxes" or because health abnormalities evolve and change over time. In addition, the book deconstructs the processes of diagnosis and explores how different stakeholders used diagnosis names for various purposes. In examining pertinent questions, the book offers a roadmap to achieving consensus definitions or including measures of uncertainty in personal care, research, and policy..Diagnoses Without Names: Challenges for Med
出版日期Book 2022
關(guān)鍵詞Clinical trials and diagnostic uncertainty; Diagnoses without names; Diagnostic certainty; Diagnostic t
版次1
doihttps://doi.org/10.1007/978-3-031-04935-4
isbn_softcover978-3-031-04934-7
isbn_ebook978-3-031-04935-4
copyrightSpringer Nature Switzerland AG 2022
The information of publication is updating

書目名稱Diagnoses Without Names影響因子(影響力)




書目名稱Diagnoses Without Names影響因子(影響力)學(xué)科排名




書目名稱Diagnoses Without Names網(wǎng)絡(luò)公開度




書目名稱Diagnoses Without Names網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Diagnoses Without Names被引頻次




書目名稱Diagnoses Without Names被引頻次學(xué)科排名




書目名稱Diagnoses Without Names年度引用




書目名稱Diagnoses Without Names年度引用學(xué)科排名




書目名稱Diagnoses Without Names讀者反饋




書目名稱Diagnoses Without Names讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:56:00 | 只看該作者
A Pragmatic Approach to Diagnostic Categorization. Sometimes pragmatic choices need to be made between candidate diagnostic frameworks. Various kinds of diagnostic difficulty are explored, including differences between research and clinical diagnostic categories, “not otherwise specified” categories, and stigmatized diagnoses.
板凳
發(fā)表于 2025-3-22 03:46:53 | 只看該作者
地板
發(fā)表于 2025-3-22 06:12:15 | 只看該作者
Toward Molecular Diagnoses for Autoimmune Rheumatic Diseasesdisorders exhibit extensive clinical and immunologic heterogeneity, and many patients present with evidence of rheumatic diseases but do not fulfill classification criteria, resulting in patient uncertainty and delays in diagnosis and treatment. Several studies have defined distinct molecular signat
5#
發(fā)表于 2025-3-22 09:07:46 | 只看該作者
6#
發(fā)表于 2025-3-22 14:06:04 | 只看該作者
Confronting the Inevitability of Diagnostic Uncertainty Across Multiple Legal Domainsd future course of a particular patient’s ailment posed no great difficulties. As external scrutiny of patient management choices has become commonplace, diagnostic uncertainty poses greater challenges. Although a temptation may exist to visit much of the blame on legal institutions, agencies and co
7#
發(fā)表于 2025-3-22 17:16:02 | 只看該作者
8#
發(fā)表于 2025-3-22 22:31:22 | 只看該作者
9#
發(fā)表于 2025-3-23 03:47:39 | 只看該作者
The Impact of Antinuclear Antibody Testing on the Naming and Misnaming of Disease autoimmunity, the antinuclear antibody (ANA) provides information that can be difficult to interpret and, thereby, can contribute to misnaming of certain signs and symptoms as an autoimmune disease, especially systemic lupus erythematosus (SLE). Although a positive ANA test is now considered necess
10#
發(fā)表于 2025-3-23 06:32:32 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-20 21:47
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
扶绥县| 黄山市| 周至县| 南溪县| 武冈市| 泸西县| 武定县| 遂溪县| 顺昌县| 大田县| 丰原市| 东丽区| 托克托县| 密云县| 永昌县| 邵阳市| 南宫市| 长武县| 嘉祥县| 辽宁省| 来宾市| 阿荣旗| 蓝山县| 房产| 兖州市| 钟祥市| 手机| 凤台县| 宾阳县| 松桃| 项城市| 兴海县| 乡宁县| 中牟县| 黔江区| 拜城县| 额济纳旗| 栖霞市| 石首市| 宁强县| 正宁县|